98 related articles for article (PubMed ID: 21782838)
1. Alternative markers for the long-term detection of oral testosterone misuse.
Fabregat A; Pozo OJ; Marcos J; Segura J; Ventura R
Steroids; 2011 Nov; 76(12):1367-76. PubMed ID: 21782838
[TBL] [Abstract][Full Text] [Related]
2. Detection of dihydrotestosterone gel, oral dehydroepiandrosterone, and testosterone gel misuse through the quantification of testosterone metabolites released after alkaline treatment.
Fabregat A; Pozo OJ; Van Renterghem P; Van Eenoo P; Marcos J; Segura J; Ventura R
Drug Test Anal; 2011; 3(11-12):828-35. PubMed ID: 21998068
[TBL] [Abstract][Full Text] [Related]
3. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
[TBL] [Abstract][Full Text] [Related]
4. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
Mazzarino M; Braganò MC; de la Torre X; Molaioni F; Botrè F
Steroids; 2011 Nov; 76(12):1400-6. PubMed ID: 21745489
[TBL] [Abstract][Full Text] [Related]
5. Alternative long-term markers for the detection of methyltestosterone misuse.
Gómez C; Pozo OJ; Marcos J; Segura J; Ventura R
Steroids; 2013 Jan; 78(1):44-52. PubMed ID: 23127819
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control.
Parr MK; Fusshöller G; Schlörer N; Opfermann G; Piper T; Rodchenkov G; Schänzer W
Rapid Commun Mass Spectrom; 2009 Jan; 23(2):207-18. PubMed ID: 19089863
[TBL] [Abstract][Full Text] [Related]
7. Testosterone metabolism revisited: discovery of new metabolites.
Pozo OJ; Marcos J; Ventura R; Fabregat A; Segura J
Anal Bioanal Chem; 2010 Oct; 398(4):1759-70. PubMed ID: 20711771
[TBL] [Abstract][Full Text] [Related]
8. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
Sobolevsky T; Rodchenkov G
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
[TBL] [Abstract][Full Text] [Related]
10. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids.
Aguilera R; Becchi M; Casabianca H; Hatton CK; Catlin DH; Starcevic B; Pope HG
J Mass Spectrom; 1996 Feb; 31(2):169-76. PubMed ID: 8799270
[TBL] [Abstract][Full Text] [Related]
11. A steroidomic approach for biomarkers discovery in doping control.
Boccard J; Badoud F; Grata E; Ouertani S; Hanafi M; Mazerolles G; Lantéri P; Veuthey JL; Saugy M; Rudaz S
Forensic Sci Int; 2011 Dec; 213(1-3):85-94. PubMed ID: 21831550
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urinary markers of oral testosterone misuse by healthy men in presence of masking epitestosterone administration.
Dehennin L; Pérès G
Int J Sports Med; 1996 Jul; 17(5):315-9. PubMed ID: 8858400
[TBL] [Abstract][Full Text] [Related]
13. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Badoud F; Boccard J; Schweizer C; Pralong F; Saugy M; Baume N
J Steroid Biochem Mol Biol; 2013 Nov; 138():222-35. PubMed ID: 23796409
[TBL] [Abstract][Full Text] [Related]
14. Sulfate metabolites improve retrospectivity after oral testosterone administration.
Esquivel A; Alechaga É; Monfort N; Ventura R
Drug Test Anal; 2019 Mar; 11(3):392-402. PubMed ID: 30362276
[TBL] [Abstract][Full Text] [Related]
15. Urine stability and steroid profile: towards a screening index of urine sample degradation for anti-doping purpose.
Mazzarino M; Abate MG; Alocci R; Rossi F; Stinchelli R; Molaioni F; de la Torre X; Botrè F
Anal Chim Acta; 2011 Jan; 683(2):221-6. PubMed ID: 21167974
[TBL] [Abstract][Full Text] [Related]
16. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264
[TBL] [Abstract][Full Text] [Related]
17. Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: inter-individual variability of 13C/12C ratio.
Baume N; Saudan C; Desmarchelier A; Strahm E; Sottas PE; Bagutti C; Cauderay M; Schumacher YO; Mangin P; Saugy M
Steroids; 2006 May; 71(5):364-70. PubMed ID: 16438998
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of boldenone in man: gas chromatographic/mass spectrometric identification of urinary excreted metabolites and determination of excretion rates.
Schänzer W; Donike M
Biol Mass Spectrom; 1992 Jan; 21(1):3-16. PubMed ID: 1591280
[TBL] [Abstract][Full Text] [Related]
19. Fractionation of free and conjugated steroids for the detection of boldenone metabolites in calf urine with ultra-performance liquid chromatography/tandem mass spectrometry.
Van Poucke C; Van Vossel E; Van Peteghem C
Rapid Commun Mass Spectrom; 2008 Aug; 22(15):2324-32. PubMed ID: 18615838
[TBL] [Abstract][Full Text] [Related]
20. Urinary marker of oral pregnenolone administration.
Saudan C; Desmarchelier A; Sottas PE; Mangin P; Saugy M
Steroids; 2005 Mar; 70(3):179-83. PubMed ID: 15763596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
